Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Chinese Academy of Medical Sciences, Langfang, China.
Colorectal Dis. 2022 Nov;24(11):1325-1334. doi: 10.1111/codi.16223. Epub 2022 Jul 1.
Lateral pelvic lymph node dissection (LPND) is a technically challenging procedure, and the safety and feasibility of laparoscopic LPND remains undetermined. Here, we compared the short- and long-term survival outcomes of laparoscopic LPND with those of open LPND.
From January 2012 to December 2019, locally advanced middle-low rectal cancer patients with clinical evidence of lateral pelvic lymph node metastasis (LPNM) who underwent total mesorectal excision with LPND at three institutions were included. Propensity score matching was used to minimize selection bias. The short-term and oncological outcomes of open and laparoscopic LPND were compared.
Overall, 384 patients were enrolled into the study including 277 and 107 patients who underwent laparoscopic and open LPND, respectively. After matching, patients were stratified into laparoscopic (n = 100) and open (n = 100) LPND groups. Patients in the laparoscopic LPND group had a shorter operation time (255 vs. 300 min, p = 0.001), less intraoperative blood loss (50 vs. 300 ml, p < 0.001), lower incidence of postoperative complications (32.0% vs. 15.0%, p = 0.005), shorter postoperative hospital stay (8 vs. 14 days, p < 0.001), and excision of more lateral pelvic lymph nodes (9 vs. 7, p = 0.025) than those in the open LPND group. The 3-year overall survival (p = 0.581) and 3-year disease-free survival (p = 0.745) rates were similar between the groups, and LPNM was an independent predictor of survival.
Laparoscopic LPND is technically safe and feasible with favourable short-term results and similar oncological outcomes as open surgery in selected patients.
侧方盆腔淋巴结清扫术(LPND)是一种技术上具有挑战性的手术,腹腔镜 LPND 的安全性和可行性仍未确定。在此,我们比较了腹腔镜 LPND 与开放 LPND 的短期和长期生存结果。
从 2012 年 1 月至 2019 年 12 月,在三个机构中,对临床有侧方盆腔淋巴结转移(LPNM)证据的局部晚期中低位直肠癌患者进行了全直肠系膜切除术和 LPND。采用倾向评分匹配来最小化选择偏倚。比较了开放和腹腔镜 LPND 的短期和肿瘤学结果。
总体而言,384 例患者入组研究,其中腹腔镜和开放 LPND 分别为 277 例和 107 例。匹配后,患者分为腹腔镜(n=100)和开放(n=100)LPND 组。腹腔镜 LPND 组的手术时间更短(255 分钟 vs. 300 分钟,p=0.001),术中出血量更少(50 毫升 vs. 300 毫升,p<0.001),术后并发症发生率更低(32.0% vs. 15.0%,p=0.005),术后住院时间更短(8 天 vs. 14 天,p<0.001),且侧方盆腔淋巴结清扫数量更多(9 枚 vs. 7 枚,p=0.025)。两组患者的 3 年总生存率(p=0.581)和 3 年无病生存率(p=0.745)相似,LPNM 是生存的独立预测因素。
在选择的患者中,腹腔镜 LPND 技术上是安全可行的,具有良好的短期结果和与开放手术相似的肿瘤学结果。